Pages that link to "Q50743494"

The following pages link to Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse. (Q50743494):

Displaying 36 items.

• Increased serum dehydroepiandrosterone sulfate in the first episode but not in subsequent episodes in male patients with schizophrenia (Q33573632) (← links)
• Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications (Q34323034) (← links)
• Clinical associations of serum interleukin-17 in systemic lupus erythematosus (Q34365880) (← links)
• Sex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia (Q35168712) (← links)
• Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis. (Q35179022) (← links)
• Pro-/antiinflammatory dysregulation in early psychosis: results from a 1-year follow-up study (Q35203663) (← links)
• The promise of biological markers for treatment response in first-episode psychosis: a systematic review (Q35369988) (← links)
• ZNF804A Transcriptional Networks in Differentiating Neurons Derived from Induced Pluripotent Stem Cells of Human Origin (Q35533016) (← links)
• Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis (Q35603078) (← links)
• Disequilibrium of Cytokine Serum Levels in Veterans With Chronic Schizophrenia Medicated With Antipsychotics: Association With Measures of Excitement and Hostility (Q36722930) (← links)
• Relationship of serum levels of TNF-α, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers (Q36956292) (← links)
• Higher Plasma S100B Concentrations in Schizophrenia Patients, and Dependently Associated with Inflammatory Markers (Q36986134) (← links)
• Inflammatory cytokine network in schizophrenia (Q38138169) (← links)
• Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders. (Q38209971) (← links)
• Functional Implications of the IL-23/IL-17 Immune Axis in Schizophrenia (Q39024232) (← links)
• Brain antibodies in the cortex and blood of people with schizophrenia and controls. (Q41687564) (← links)
• Immunomodulatory Effects of Probiotic Supplementation in Schizophrenia Patients: A Randomized, Placebo-Controlled Trial (Q41861999) (← links)
• Interleukin-6 in Schizophrenia-Is There a Therapeutic Relevance? (Q47155489) (← links)
• Association of psychosis, affective disorders and diseases affecting the immune system (Q47574105) (← links)
• A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression (Q48063321) (← links)
• Association between increased serum interleukin-6 levels and sustained attention deficits in patients with major depressive disorder (Q50130902) (← links)
• IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis. (Q55514878) (← links)
• The Emerging Field of Nutritional Mental Health (Q56675883) (← links)
• Inflammatory Markers in Anorexia Nervosa: An Exploratory Study (Q57793855) (← links)
• The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review (Q58122198) (← links)
• A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis (Q58589435) (← links)
• Maternal immune activation leads to age-related behavioral and immunological changes in male rat offspring - the effect of antipsychotic drugs (Q60445730) (← links)
• Peripheral Biomarkers for First-Episode Psychosis-Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia (Q64123533) (← links)
• Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition (Q88140050) (← links)
• Interleukin-17 Alteration in First-Episode Psychosis: A Meta-Analysis (Q88208121) (← links)
• Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models (Q88618985) (← links)
• Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation (Q89490494) (← links)
• Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity (Q89631151) (← links)
• Serum galectin-3 levels are decreased in schizophrenia (Q90231473) (← links)
• Reduced regulatory T cells with increased proinflammatory response in patients with schizophrenia (Q90715930) (← links)
• Cytokine Alterations in Schizophrenia: An Updated Review (Q92462310) (← links)